Skip to main content

Cosmos Health Inc.

COSM
Exchange
Nasdaq
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
SEC CIK
0001474167

In the last 90 days, Cosmos Health Inc. insiders filed 2 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $389.5K in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Cosmos Health Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
2 filings
1 insider, $210.0K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$210.0K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Cosmos Health Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Cosmos Health Inc.
NameTitleLast reported holdingLast filingFilings, past year
Siokas GrigoriosChief Executive Officer14,597,917Jul 31, 202621
Terzis GeorgiosChief Financial Officer2,563,805Jul 30, 20263
Karkantzos Theodoros ChristosDirector35,000Jun 11, 20261
Hoidas John JamesDirector50,000Jun 11, 20261
Demetriades Demetrios G.Secretary55,000Jun 11, 20261
Aslidis AnastasiosDirector100,000Jun 11, 20261
Bhutawala SuhelDirector65,000Jun 11, 20261
Ziegler ManfredDirector5,000Aug 4, 20230
Bardakis NikolaosChief Operating Officer10,000Aug 1, 20230
Ignatiades PavlosChief Communications Officer5,000Jul 28, 20230
Goldstein PeterDirector, 10% Owner157,100Jul 28, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 9, 2026 (view filing)Jan 81 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+156.2K$0.52+$81.2K+2.2%7.13M after
Jan 13, 2026 (view filing)Jan 121 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+113.2K$0.50+$56.6K+1.6%7.24M after
Jan 15, 2026 (view filing)9:40 AM ETJan 141 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+493.5K$0.4458+$220.0K+6.8%7.74M after
Jan 21, 2026 (view filing)Jan 201 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+353.3K$0.50+$176.7K+4.6%8.09M after
Jan 26, 2026 (view filing)Jan 233 daysSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+90.3K$0.50+$45.2K+1.1%8.18M after
Feb 12, 2026 (view filing)2:20 PM ETFeb 111 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+291.3K$0.412+$120.0K+3.6%8.47M after
Feb 13, 2026 (view filing)10:05 AM ETFeb 121 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+388.5K$0.3732+$145.0K+4.6%8.86M after
Jun 12, 2026 (view filing)6:20 AM ETJun 102 daysSiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+701.4K$0.2281+$160.0K+5.6%13.3M after
Jun 12, 2026 (view filing)1:22 PM ETJun 111 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+218.4K$0.206+$45.0K+1.6%13.5M after
Jun 17, 2026 (view filing)9:15 AM ETJun 161 dayTerzis GeorgiosChief Financial OfficerPPurchaseCommon Stock, par value $.001+168.1K$0.2498+$42.0K+8.1%2.24M after
Jul 30, 2026 (view filing)11:09 AM ETJul 291 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+766.3K$0.1827+$140.0K+5.7%14.2M after
Jul 31, 2026 (view filing)11:52 AM ETJul 301 daySiokas GrigoriosChief Executive OfficerPPurchaseCommon Stock, par value $.001+349.8K$0.2001+$70.0K+2.5%14.6M after